- $17.69bn
- $18.34bn
- $4.03bn
- 84
- 35
- 87
- 77
Annual income statement for Hologic, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 28th | 2020 September 26th | 2021 September 25th | 2022 September 24th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,367 | 3,776 | 5,632 | 4,863 | 4,030 |
| Cost of Revenue | |||||
| Gross Profit | 1,750 | 2,253 | 3,796 | 3,015 | 2,251 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,492 | 2,671 | 3,174 | 3,223 | 3,362 |
| Operating Profit | -125 | 1,105 | 2,459 | 1,640 | 668 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -258 | 1,002 | 2,361 | 1,588 | 676 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -199 | 1,111 | 1,870 | 1,302 | 456 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -204 | 1,115 | 1,872 | 1,302 | 456 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -204 | 1,115 | 1,872 | 1,302 | 456 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.934 | 4.33 | 7.3 | 5.28 | 2.61 |